Saba Capital Management, L.P. sold HQL

February 13, 2025 · Form 4 insider transaction

Saba Capital Management, L.P. sold 100 shares of Abrdn Life Sciences Investors at $13.88 per share, a transaction worth $1.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 5 days after the transaction.